73204-06-5 Usage
Uses
Used in Organic Synthesis:
4-Benzoylamino cyclohexanone serves as a key intermediate in the synthesis of a variety of pharmaceutical drugs and other organic compounds. Its unique structure allows for the creation of complex molecules that are otherwise challenging to produce.
Used in Pharmaceutical Research:
In the pharmaceutical industry, 4-Benzoylamino cyclohexanone is utilized for the development of new drugs. Its properties make it a valuable component in the formulation of medications targeting a range of health conditions.
Used in Material Development:
4-Benzoylamino cyclohexanone may also have potential applications in the development of new materials, where its chemical reactivity and structural attributes can contribute to the creation of innovative substances with unique properties.
Used as a Reagent in Chemical Reactions:
4-Benzoylamino cyclohexanone is employed as a reagent in various chemical reactions, facilitating processes that require its specific chemical characteristics to achieve desired outcomes in research and industrial settings.
The synthesis and study of 4-Benzoylamino cyclohexanone continue to be of interest in the scientific community, as advancements in its understanding can lead to further applications and enhancements in existing uses across different industries.
Check Digit Verification of cas no
The CAS Registry Mumber 73204-06-5 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 7,3,2,0 and 4 respectively; the second part has 2 digits, 0 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 73204-06:
(7*7)+(6*3)+(5*2)+(4*0)+(3*4)+(2*0)+(1*6)=95
95 % 10 = 5
So 73204-06-5 is a valid CAS Registry Number.
InChI:InChI=1/C13H15NO2/c15-12-8-6-11(7-9-12)14-13(16)10-4-2-1-3-5-10/h1-5,11H,6-9H2,(H,14,16)
73204-06-5Relevant articles and documents
NOVEL BRONCHODILATING DIAZAHETEROARYLS
-
Page/Page column 59-60, (2012/03/08)
The invention relates to novel compounds having the general formula (I), and which compounds are useful to treat a disorder or disease characterized by bronchoconstriction, e.g. COPD and asthma.
NOVEL BRONCHODILATING DIAZAHETEROARYLS
-
Page/Page column 128, (2010/09/17)
The invention relates to novel compounds having the general formula (I), and which compounds are useful to treat a disorder or disease characterized by bronchoconstriction, e.g. COPD and asthma.
